Key result
Review highlights semaglutide for managing peripheral artery disease in diabetes.
Weekly journal scan reveals semaglutide improves management of peripheral artery disease and diabetes.
Journal Article Weekly Journal Scan: semaglutide in patients with peripheral artery disease and diabetes—a real STRIDE in their management? Get access Rocco Vergallo, Rocco Vergallo Interventional Cardiology Unit, Cardiothoracic and Vascular Department (DICATOV), IRCCS Ospedale Policlinico San Martino, Largo R. Benzi, 10, Genoa 16132, ItalyDepartment of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Viale Benedetto XV, 6, Genoa 16132, Italy Corresponding author. Tel: 0039 0105555830, Fax: 0039 0105556513, Emails: [email protected], [email protected] https://orcid.org/0000-0001-5577-081X Search for other works by this author on: Oxford Academic PubMed Google Scholar Giovanna Liuzzo Giovanna Liuzzo Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli—IRCCS, Largo A. Gemelli 8, Rome 00168, ItalyDepartment of Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine, Largo F. Vito 1, Rome 00168, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, ehaf535, https://doi.org/10.1093/eurheartj/ehaf535 Published: 05 September 2025
No takes yet. Share an insight, caveat, or question.
Vergallo et al. (2025) conducted a review in peripheral artery disease and diabetes. semaglutide was evaluated. A weekly journal scan discussed the role of semaglutide in the management of patients with peripheral artery disease and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: